SCHEMBL23853748

SCHEMBL23853748

N#Cc1c(-c2cccs2)nc(C(S)c2cccc(S(N)(=O)=O)c2)[nH]c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 5/20 0.48
RXFP1 Q9HBX9 5/20 0.48
NPSR1 Q6W5P4 4/20 0.48
KDM4E B2RXH2 3/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ACMSD Q8TDX5 7/20 0.43
CYP2C19 P33261 2/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42
PKM P14618 1/20 0.42
BLM P54132 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PSMD14 O00487 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23849891 0.83 ACMSD (0.51) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL23849994 0.82 ACMSD (0.61) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL23850126 0.76 ACMSD (0.52) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL31313993 0.76 ACMSD (0.70) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL23853749 0.76 ACMSD (0.70) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL24088115 0.71 PRNP (0.67) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL24087889 0.69 PRNP (0.65) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL31053407 0.66 PRNP (0.63) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL24087985 0.66 RXFP1 (1.00) PRNPRXFP1NPSR1KDM4EMAPT
SCHEMBL26847398 0.66 HPGD (0.64) PRNPRXFP1NPSR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883930-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE Tes Pharma S.r.l. (IT) 2021-09-29 EP disclosed